Using alternative medicine to treat cancer, even alongside conventional therapies, is still a bad idea
By David Gorski
The MAHA movement is pushing for more integrative and complementary treatments in oncology, but a new study warns this path could backfire. Mixing unproven “alternative” options with conventional cancer care may undermine effectiveness, cause delays in proven therapies, or introduce safety risks. The takeaway: patients and clinicians should approach integrative ideas with caution, prioritizing evidence-backed treatments and clear communication about benefits and harms. If you’re weighing options, seek guidance from trusted medical professionals and scrutinize claims that sound promising but lack solid data.
